Aulos Bioscience Revenue and Competitors
Estimated Revenue & Valuation
- Aulos Bioscience's estimated annual revenue is currently $1.3M per year.
- Aulos Bioscience's estimated revenue per employee is $77,500
- Aulos Bioscience's total funding is $60M.
Employee Data
- Aulos Bioscience has 17 Employees.
- Aulos Bioscience grew their employee count by 6% last year.
Aulos Bioscience's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Operating Officer and Co-Founder | Reveal Email/Phone |
2 | Co-Founder and CSO | Reveal Email/Phone |
3 | Chief Financial Officer | Reveal Email/Phone |
4 | CMO Aulos Bioscience | Reveal Email/Phone |
5 | Chief Scientific Officer | Reveal Email/Phone |
6 | Chief Operating Officer | Reveal Email/Phone |
7 | Chief Medical Officer | Reveal Email/Phone |
8 | SVP and Head Early Development | Reveal Email/Phone |
9 | Head Clinical Operations | Reveal Email/Phone |
10 | Associate Director | Reveal Email/Phone |
Aulos Bioscience Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.4M | 70 | -8% | $53M | N/A |
#2 | $32.4M | 167 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.8M | 18 | 13% | N/A | N/A |
#5 | $0.8M | 5 | -50% | N/A | N/A |
#6 | $0.8M | 10 | 0% | N/A | N/A |
#7 | $14M | 90 | -12% | N/A | N/A |
#8 | $0.4M | 336 | 10% | $236.7M | N/A |
#9 | $4.8M | 62 | -74% | $160M | N/A |
#10 | $3.7M | 24 | -8% | N/A | N/A |
What Is Aulos Bioscience?
Aulos Bioscience is an immuno-oncology company revolutionizing cancer patient care through best-in-class IL-2 therapeutics computationally designed to exquisitely direct patients’ own immune systems towards killing tumor cells.Matching world-class machine learning from founder and partner Biolojic Design with an in-depth understanding of the immune system, Aulos’ initial clinical candidate, AU-007, has been designed to harness the power of a patient’s own IL-2 to induce tumor killing while limiting the immunosuppression and toxicities typically associated with this validated class of therapeutics.AU-007 has the potential to become a best-in-class treatment for solid tumors. The company was founded by Biolojic Design and ATP with $40M in Series A funding from ATP and is led by pioneers in the field of artificial intelligence, antibody development and cancer immunotherapies. For more information, visit aulosbio.com.
keywords:N/A
$60M
Total Funding
17
Number of Employees
$1.3M
Revenue (est)
6%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Larkspur
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.8M | 20 | 33% | N/A |
#2 | $3.1M | 21 | 0% | N/A |
#3 | $4.2M | 22 | -31% | N/A |
#4 | $4.2M | 22 | 0% | N/A |
#5 | $2M | 24 | N/A | N/A |